BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 699246)

  • 21. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.
    Monrad ES; Baim DS; Smith HS; Lanoue A; Brauwald E; Grossman W
    Circulation; 1985 May; 71(5):972-9. PubMed ID: 3986984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
    Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure.
    Franciosa JA; Cohn JN
    Am J Cardiol; 1979 May; 43(5):1009-14. PubMed ID: 433762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of converting-enzyme inhibition on cardiorenal hemodynamics in patients with chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    J Cardiovasc Pharmacol; 1985; 7(4):753-9. PubMed ID: 2410718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in man.
    Niarchos AP; Roberts AJ; Laragh JH
    Am J Med; 1979 Nov; 67(5):785-91. PubMed ID: 315711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between exogenous atrial natriuretic peptide and hemodynamics in dogs with congestive heart failure produced by experimental mitral regurgitation.
    Asano K; Masuda K; Okumura M; Kadosawa T; Fujinaga T
    J Vet Med Sci; 2001 Mar; 63(3):243-50. PubMed ID: 11307923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.
    Holt P; Najm J; Sowton E
    Eur J Clin Pharmacol; 1986; 31(1):9-14. PubMed ID: 3023100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of chronic congestive heart-failure by oral captopril.
    Turini GA; Brunner HR; Gribic M; Waeber B; Gavras H
    Lancet; 1979 Jun; 1(8128):1213-5. PubMed ID: 87679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
    Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W
    Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute hemodynamic effects of alifedrine in patients with heart failure].
    Schanzenbächer P; Riegger G; Liebau G; Hockerts T; Kochsiek K
    Z Kardiol; 1984 Feb; 73(2):95-100. PubMed ID: 6719988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-related hemodynamic and renal effects of dopamine in congestive heart failure.
    Beregovich J; Bianchi C; Rubler S; Lomnitz E; Cagin N; Levitt B
    Am Heart J; 1974 May; 87(5):550-7. PubMed ID: 4818699
    [No Abstract]   [Full Text] [Related]  

  • 33. Myocardial and vascular effects of intracoronary versus intravenous milrinone.
    Colucci WS; Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E
    Trans Assoc Am Physicians; 1985; 98():136-45. PubMed ID: 3842193
    [No Abstract]   [Full Text] [Related]  

  • 34. Systemic and regional hemodynamic effects of isomazole in awake dogs with congestive heart failure.
    Imai N; Liang CS; Stone CK; Hayes JS; Hood WB
    J Pharmacol Exp Ther; 1987 Apr; 241(1):20-6. PubMed ID: 3572783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and hemodynamic experience with enalapril in congestive heart failure.
    Cody RJ
    Am J Cardiol; 1985 Jan; 55(2):36A-40A. PubMed ID: 2981464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemodynamic effects of insulin and beta receptor blockade during acute left ventricular failure in dogs.
    Reikerås O; Gunnes P; Sørlie D; Ekroth R; Mjøs OD
    Eur Heart J; 1986 Mar; 7(3):227-33. PubMed ID: 3519226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure.
    Pelliccia F; Borghi A; Ruggeri A; Cianfrocca C; Morgagni GL; Bugiardini R
    Clin Cardiol; 1993 Aug; 16(8):607-12. PubMed ID: 8370193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
    Cody RJ
    Drugs; 1984 Aug; 28(2):144-69. PubMed ID: 6205842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pentoxifylline on central hemodynamics in patients with congestive heart failure.
    Nordhus O; Ekeström S; Liljeqvist L
    Scand J Thorac Cardiovasc Surg; 1986; 20(3):217-20. PubMed ID: 3810089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute myocardial infarction in man. Comparative hemodynamic effects of norepinephrine and glucagon.
    Diamond G; Forrester J; Danzig R; Parmley WW; Swan HJ
    Am J Cardiol; 1971 Jun; 27(6):612-6. PubMed ID: 5092474
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.